3D Bioprinting as an In Vitro Tool to Model the Tumor Microenvironment
Seminars in Cancer Biology · 2026-11 · 102636
DOI: 10.1016/j.semcancer.2026.102636 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2026-11. Verfasst von Zahra Mantaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: VoxCell BioInnovation Inc., Victoria, B.C, Canada. Die Arbeit nennt 297 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Three‑dimensional (3D) bioprinting has rapidly emerged as a powerful strategy for engineering physiologically relevant tumor microenvironment (TME) models that overcome the limitations of traditional 2D cultures and animal systems. The TME is a highly dynamic and heterogeneous ecosystem composed of malignant, stromal, immune, and vascular cells embedded within a biochemically and mechanically complex extracellular matrix (ECM). These components collectively regulate tumor progression, immune evasion, metastasis, and therapeutic resistance. Conventional preclinical models fail to capture this complexity, contributing to poor clinical translation of oncology therapeutics. Advances in extrusion‑based, inkjet, laser‑assisted, and stereolithographic bioprinting now enable spatially organized, multicellular constructs with tunable biochemical and biophysical cues that more accurately recapitulate TME architecture and function. Complementary innovations in biomaterials, microfluidics, and computational modeling further expand the capabilities of bioprinted systems for drug screening, mechanistic studies, and personalized medicine. This review summarizes the cellular and acellular components of the TME, outlines major bioprinting technologies and biomaterial strategies, and highlights emerging applications in cancer modeling. We also identify key research gaps and opportunities that must be addressed to advance bioprinted TME platforms toward robust, standardized, and clinically meaningful tools for precision oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VoxCell BioInnovation Inc., Victoria, B.C, Canada.
- Biomedical Systems Program, University of Victoria, Victoria, BC, Canada.
- Biomedical Systems Program, University of Victoria, Victoria, BC, Canada; Department of Mechanical Engineering and School of Medical Sciences, University of Victoria, Victoria, BC, Canada; School of Biomedical Engineeri…
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Mantaka, Z., Shteinberg, E., Le Roux, M., Mirani, B., & Willerth, S. M. (2026). 3D Bioprinting as an In Vitro Tool to Model the Tumor Microenvironment. Seminars in Cancer Biology, 102636. https://doi.org/10.1016/j.semcancer.2026.102636
Vancouver
Mantaka Z, Shteinberg E, Le Roux M, Mirani B, Willerth SM. 3D Bioprinting as an In Vitro Tool to Model the Tumor Microenvironment. Seminars in Cancer Biology. 2026:102636. doi:10.1016/j.semcancer.2026.102636
BibTeX
@article{Mantaka2026,
author = {Mantaka, Zahra and Shteinberg, Ekaterina and Le Roux, Matthew and Mirani, Bahram and Willerth, Stephanie M},
title = {3D Bioprinting as an In Vitro Tool to Model the Tumor Microenvironment},
journal = {Seminars in Cancer Biology},
year = {2026},
pages = {102636},
doi = {10.1016/j.semcancer.2026.102636}
}
EUVIMED